Literature DB >> 4156410

Sedative effects on physiological and psychological measures in anxious patients.

A J Bond, D C James, M H Lader.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4156410     DOI: 10.1017/s0033291700045815

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


× No keyword cloud information.
  9 in total

1.  Anxiety reduction and sedation: psychophysiological theory.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Conditioned emotional responding under diazepam: a psychophysiological study of state dependent learning.

Authors:  H H Jensen; B Hutchings; J C Poulsen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

4.  Plasma concentrations of benzodiazepines.

Authors:  A J Bond; D M Hailey; M H Lader
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

5.  Withdrawal from long-term benzodiazepine treatment.

Authors:  H Petursson; M H Lader
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

6.  A comparison of the clinical and psychological effects of diazepam and amylobarbitone in anxious patients.

Authors:  C Z Tansella; M Tansella; M Lader
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

7.  Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG.

Authors:  A Bond; M Lader; R Shrotriya
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.

Authors:  K M S Kanhai; R G J A Zuiker; I Stavrakaki; W Gladdines; P J Gaillard; E S Klaassen; G J Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2018-03-09       Impact factor: 4.335

9.  Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial.

Authors:  Gerson D Hernandez; Christine M Solinsky; Wendy J Mack; Naoko Kono; Kathleen E Rodgers; Chun-Yi Wu; Ana R Mollo; Claudia M Lopez; Sonia Pawluczyk; Gerhard Bauer; Dawn Matthews; Yonggang Shi; Meng Law; Michael A Rogawski; Lon S Schneider; Roberta D Brinton
Journal:  Alzheimers Dement (N Y)       Date:  2020-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.